The University of Chicago Header Logo

A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).

A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC). J Clin Oncol. 2005 Jun; 23(16_suppl):4669.

View in: PubMed